Stock YEWB YEW BIO-PHARM GROUP, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Yew Bio-Pharm Group, Inc.

Equities

YEWB

US98584C1018

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
YEW BIO-PHARM GROUP, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
Yew Bio-Pharm Group, Inc. Announces Yongchun Shi and Mr. Xiefeng Liu Resigned as the Independent Director
CI
YEW BIO-PHARM GROUP, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
Yew Bio-Pharm Group, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
YEW BIO PHARM : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
Yew Bio-Pharm Group, Inc. Announces Earnings Results for the Second Quarter Ended June 30, 2021
CI
YEW BIO-PHARM GROUP, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
Yew Bio-Pharm Group, Inc. Announces Executive Changes
CI
Yew Bio-Pharm Group, Inc. Announces Executive Changes
CI
Yew Bio-Pharm Group, Inc. Announces Executive Changes
CI
YEW BIO PHARM : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
Yew Bio-Pharm Group, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
YEW BIO P : PHARM GROUP, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
Yew Bio-Pharm Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020
CI
Yew Bio Pharm : Announces New Cosmetic Subsidiary
AQ
Yew Bio-Pharm Group, Inc. Announces New Cosmetic Subsidiary
CI
YEW BIO-PHARM GROUP, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
Yew Bio-Pharm Group, Inc. Announces Resignation of Guoshuang Tian as Director
CI
Yew Bio-Pharm Group, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020
CI
YEW BIO PHARM : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. YEWB Stock
  4. News Yew Bio-Pharm Group, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW